ArticleProstate international2020

Cyclooxygenase-2 inhibitors delay relapse and reduce Prostate Specific Antigen (PSA) velocity in patients treated with radiotherapy for nonmetastatic prostate cancer: a pilot study.

Liam King et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.